SLC2A1 and nasopharyngeal carcinoma: Glut-1–specific chemical inhibitors, including STF-31, have shown to have a strong effect to selectively kill NPC cells in vitro (Chan et al., 2011; Liu Y et al., 2012; Zhang et al., 2017).